• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮抗凝物的物种特异性。

Species specificity of lupus-like anticoagulants.

作者信息

Clyne L P

出版信息

Blut. 1986 Oct;53(4):287-92. doi: 10.1007/BF00320886.

DOI:10.1007/BF00320886
PMID:3092891
Abstract

Mixing studies using activated partial thromboplastin time (APTT) technique were performed on 14 patients with lupus-like anticoagulants (LLACs) using human, equine, bovine, porcine and canine plasma. Eleven patients significantly prolonged the APTT of normal human plasma (patient/control ratio = greater than 1.15) but no patient inhibited bovine plasma. However, with one exception, equine APTT ratios were concordant with human ratios. Seven of fourteen patients also inhibited porcine plasma but in each case porcine APTT ratios were lower than their human or equine counterparts. None of five patients tested inhibited canine plasma. Collectively, these results suggest heterogeneity among LLACs at least with regard to species specificity.

摘要

采用活化部分凝血活酶时间(APTT)技术,使用人、马、牛、猪和犬血浆对14例狼疮抗凝物(LLAC)患者进行了混合试验研究。11例患者显著延长了正常人血浆的APTT(患者/对照比值大于1.15),但没有患者抑制牛血浆。然而,除1例例外,马APTT比值与人的比值一致。14例患者中有7例也抑制猪血浆,但在每种情况下,猪APTT比值均低于其对应的人或马的APTT比值。5例接受检测的患者均未抑制犬血浆。总体而言,这些结果表明LLAC之间至少在物种特异性方面存在异质性。

相似文献

1
Species specificity of lupus-like anticoagulants.狼疮抗凝物的物种特异性。
Blut. 1986 Oct;53(4):287-92. doi: 10.1007/BF00320886.
2
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
Thromb Haemost. 1984 Jul 29;51(3):317-20.
3
Similar mechanism of various lupus anticoagulants.各种狼疮抗凝物的相似机制。
Thromb Haemost. 1985 Feb 18;53(1):15-8.
4
The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.通过活化部分凝血活酶时间诊断狼疮抗凝物——磷脂酰丝氨酸的核心作用
Thromb Haemost. 1984 Oct 31;52(2):172-5.
5
Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.活化部分凝血活酶时间延长患者中狼疮抗凝物与抗心磷脂抗体的相关性
Am J Med. 1990 Feb;88(2):112-6. doi: 10.1016/0002-9343(90)90458-p.
6
Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.十六种活化部分凝血活酶时间(APTT)试剂对狼疮抗凝物存在情况的敏感性。
Haemostasis. 1995 May-Jun;25(3):98-105. doi: 10.1159/000217148.
7
Comparison of two simple tests for the lupus anticoagulant.两种狼疮抗凝物简易检测方法的比较
Am J Clin Pathol. 1985 Feb;83(2):215-8. doi: 10.1093/ajcp/83.2.215.
8
Clinical manifestations and laboratory findings in patients with lupus anticoagulants.狼疮抗凝物患者的临床表现及实验室检查结果
Eur J Haematol. 1989 Jan;42(1):90-5. doi: 10.1111/j.1600-0609.1989.tb00253.x.
9
The association of lupus anticoagulant and anti-DNA binding in patients with systemic lupus erythematosus.
Cleve Clin Q. 1985 Summer;52(2):115-8. doi: 10.3949/ccjm.52.2.115.
10
Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.人蛋白C激活剂Protac对血浆活化部分凝血活酶时间的比较效应,特别涉及犬类
Can J Vet Res. 2000 Apr;64(2):117-22.

本文引用的文献

1
NATURALLY OCCURRING SPECIES SPECIFIC INHIBITOR OF HUMAN PROTHROMBIN IN LUPUS ERYTHEMATOSUS.狼疮中天然存在的人凝血酶原特异性抑制剂。
Proc Soc Exp Biol Med. 1964 Jun;116:359-61. doi: 10.3181/00379727-116-29247.
2
In vitro correction of anticoagulant activity and specific clotting factor assays in SLE.系统性红斑狼疮中抗凝活性的体外校正及特定凝血因子检测
Thromb Res. 1980 Jun 1;18(5):643-55. doi: 10.1016/0049-3848(80)90219-4.
3
The lupus inhibitor: a study of its heterogeneity.狼疮抑制剂:对其异质性的一项研究。
Thromb Haemost. 1981 Dec 23;46(4):734-9.
4
The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.通过活化部分凝血活酶时间诊断狼疮抗凝物——磷脂酰丝氨酸的核心作用
Thromb Haemost. 1984 Oct 31;52(2):172-5.
5
Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
Thromb Haemost. 1984 Jul 29;51(3):317-20.
6
Circulating anticoagulant in disseminated lupus erythematosus. Proposed mode of action.播散性红斑狼疮中的循环抗凝物质。作用方式探讨。
Haemostasis. 1973;2(6):253-9. doi: 10.1159/000214029.
7
Similar mechanism of various lupus anticoagulants.各种狼疮抗凝物的相似机制。
Thromb Haemost. 1985 Feb 18;53(1):15-8.
8
A clinical study of the lupus anticoagulant.狼疮抗凝物的临床研究。
Blood. 1976 Oct;48(4):499-509.
9
A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.一种用于检测狼疮抗凝物及其行为模式的敏感试验。
Br J Haematol. 1978 Sep;40(1):143-51. doi: 10.1111/j.1365-2141.1978.tb03648.x.
10
The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant.部分凝血活酶时间和凝血酶原时间试剂在检测狼疮样抗凝物时的不同敏感性。
Scand J Haematol. 1979 May;22(5):423-32. doi: 10.1111/j.1600-0609.1979.tb00440.x.